Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Rev Esp Anestesiol Reanim ; 62(9): 495-501, 2015 Nov.
Artículo en Inglés, Español | MEDLINE | ID: mdl-25887095

RESUMEN

BACKGROUND AND OBJECTIVE: Droperidol and ondansetron prolong QT interval, a circumstance that has raised some concerns regarding the possibility of inducing torsades de pointes (TdP). However drug-induced spatial dispersion of ventricular repolarization has been shown to be the principal arrhythmogenic substrate for TdP. The aim of this study is to explore the effects of droperidol and ondansetron on the dispersion of repolarization, measured using the T peak-to-end interval (Tp-e) and Tp-e/QT and Tp-e/RR(1/2) ratios in surgical anesthetized patients. METHODS: A randomized, double-blind study carried out on sixty-three adult patients without cardiac disease or factors favoring QT prolongation and undergoing non-cardiac surgery were randomly assigned to the droperidol or ondansetron group. Under propofol anesthesia, a 12-lead EKG was obtained, and 1.25mg droperidol or 4mg ondansetron was injected. Five minutes later, a new 12-lead EKG was recorded. EKG analyses were independently performed by two cardiologists blinded to the state of the traces or group allocation. QT, RR and Tp-e intervals were measured by averaging five successive beats in leadII (QT) or V5 (Tp-e). The mean value for each measurement was calculated for statistical analysis. RESULTS: Thirty-two patients (19 women) received droperidol, and 31 (22 women) ondansetron. Droperidol and ondansetron prolonged the QTcF interval (Fridericia formula) by 6.8 and 7.2ms (mean values) respectively, but neither droperidol nor ondansetron increased the Tp-e interval or Tp-e/QT and Tp-e/RR(1/2) ratios. CONCLUSION: At antiemetic doses, neither ondansetron (4mg) nor droperidol (1.25mg) increases the dispersion of ventricular repolarization in healthy adult patients anesthetized with propofol.


Asunto(s)
Antieméticos/farmacología , Droperidol/farmacología , Electrocardiografía/efectos de los fármacos , Sistema de Conducción Cardíaco/efectos de los fármacos , Ondansetrón/farmacología , Adulto , Anestesia General , Anestesia Intravenosa , Antieméticos/uso terapéutico , Método Doble Ciego , Droperidol/uso terapéutico , Femenino , Sistema de Conducción Cardíaco/fisiología , Ventrículos Cardíacos/efectos de los fármacos , Humanos , Masculino , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Persona de Mediana Edad , Conducción Nerviosa/efectos de los fármacos , Conducción Nerviosa/fisiología , Ondansetrón/uso terapéutico , Náusea y Vómito Posoperatorios/prevención & control
2.
Rev Esp Anestesiol Reanim ; 62(1): 42-5, 2015 Jan.
Artículo en Inglés, Español | MEDLINE | ID: mdl-24775406

RESUMEN

Friedreich ataxia (FA) is an inherited autosomal recessive disease characterized by a neurological degenerative process of the cerebellum, spinal cord, and peripheral nerves. FA is associated with ataxia, dysarthria, motor and sensory impairment, scoliosis, cardiomyopathy, and diabetes. There is a significant risk of perioperative major complications during the anesthetic management of these patients. We present the case of a fourteen-year-old patient with FA, who had a posterior spinal fusion and instrumentation underwent to total intravenous anesthesia.


Asunto(s)
Anestesia Intravenosa/métodos , Ataxia de Friedreich/complicaciones , Escoliosis/cirugía , Fusión Vertebral , Adolescente , Arritmias Cardíacas/prevención & control , Cardiomiopatía Hipertrófica/diagnóstico por imagen , Cardiomiopatía Hipertrófica/etiología , Disnea/etiología , Femenino , Humanos , Hipotensión Controlada , Fijadores Internos , Complicaciones Intraoperatorias/prevención & control , Medicación Preanestésica , Implantación de Prótesis , Escoliosis/etiología , Fusión Vertebral/instrumentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...